×
ADVERTISEMENT

Eloctate

Real-World Trial Points to a Winner in Severe Heme A

Real-world findings from more than 200 patients treated with either recombinant FVIII Fc fusion protein (rFVIIIFc; ...

AUGUST 22, 2018

Load more